These results were consistent with those from METH-treated mice and cultured PASMCs treated with METH, confirming that Nupr1 indeed mediated the increase of STIM1 expression and induced the phenotypic transformation of PASMCs, which might be the underlying mechanism of human METH-related PAH. The gene discussed is NUPR1; the disease is pulmonary arterial hypertension.